MCSTAP Case Discussion Series: Session Two: Communication Skills for Higher Risk Substance Use: Leveraging Principles of Harm Reduction - April 29, 2026

This site is for learners who attended the live April 29, 2026, program to claim credit.

Claiming Credit 

Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.

ADA statement: To request reasonable accommodations for a disability please contact [email protected], in writing, at least two weeks prior to the activity.

Target Audience

Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants

Learning Objectives

Upon completion of this activity, participants will be able to:
  1. Explore clinician-level emotions and reactions that both hinder and facilitate effective communication, clinical decision making, and rapport.
  2. List core principles of harm reduction that guide therapeutic responses to active substance use.
  3. Describe communication skills that reduce stigma, build rapport, and increase engagement in ongoing care.
  4. Describe a Six-Part Framework that guides harm reduction-informed communication techniques rooted in humility, patient autonomy and honoring our patients’ wisdom.

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Course opens: 
04/29/2026
Course expires: 
05/29/2026
Rating: 
0
Zoom
United States
MCSTAP Medical Director, CME Course Director
Christopher Shanahan, MD, MPH, FACP
 
Faculty
Jennifer Bradford, MD, MPH
Assistant Professor, UMass Chan Medical School
MCSTAP Physician Consultant
 
Amber L. Cahill, PsyD
Associate Director, Center for Integrated Primary Care, UMass Chan Medical School
 
BU CCE Operations Manager: Naomi Moeller

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Please login or register to take this course.